Antitumor pharmaceutical composition comprising IL-6 transfected

Details Antitumor pharmaceutical composition comprising IL-6 transfected Antitumor pharmaceutical composition comprising IL-6 transfected

1995-04-28

1999-05-11

Crouch, Deborah

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

514 44, 435325, 435366, A61K48/00

Patent

active

059025760

ABSTRACT:
An anti-tumor pharmaceutical composition includes cells into which a gene encoding human IL-6 has been inserted. A method of treatment of a patient suffering from cancer to prevent and/or inhibit the development of metastases by administering to the patient the anti-tumor pharmaceutical composition including the above mentioned cells.

REFERENCES:
patent: 5188828 (1993-02-01), Goldberg et al.
Vieweg et al (1995) Cancer Investigation 13, 193-201.
Zilberstein et al., The EMBO Journal, vol. 5, No. 10, pp. 2529-2537 (1986).
Black et al, Endocrinology, vol. 128 No. 5, pp. 2657-2659 (May 1991).
Mullen et al, Cancer Res, vol. 52, pp. 6020-6024 (Nov. 1, 1992).
Scala et al, J. Exp. Med. vol. 172 pp. 61-62 (Jul. 1990).
Mule et al., J. Exp. Med., vol. 171 pp. 629-636 (Mar. 1990).
Porgador et al., "Interleukin 6 gene transfection into Lewis lung carcinoma umor cells suppresses the malignant phenotype . . ." Cancer Research, 52:3679-3686 (1992).
Russell, SJ. "Lymphokine gene therapy for cancer" Immunotherapy Today, vol. 11, No. 6, pp. 196-200 (1990).
Revel, M., Experientia 45:549-55 (1989).
Kishimoto, T., Blood 74:1-10 (1989).
Sehgal, P., Proc. Soc. Exp. Biol. Med. 195:183-191 (1990).
Eisenbach, L., et al., Int. J. Cancer 34:567-573 (1984).
Plaksin, D., et al., Proc. Natl. Acad. Sci. USA 85:4463-4467 (1988).
Southern, P., et al., J. Mol. Appl. Genet. 1:327-341 (1982).
Watanabe, Y., et al., Proc. Natl. Acad. Sci. USA 86:9456-9460 (1989).
Gansbacher, B., et al., Cancer Res. 50:7820-7825 (1990).
Fearon, E., et al., Cell. 60:397-403 (1990).
Ley, V., et al., Eur. J. Immunol. 21:851-854 (1991).
Gansbacher, B., et al., J. Exp. Med. 172:1217-1224 (1990).
Tepper, R., et al., Cell. 57:503-512 (1989).
Chirgwin, J. et al., Biochemistry 18:5294-5298 (1979).
Ozato, K. et al., J. Immunol. 126:317-321 (1981).
Eldar H., et al., J. Biological Chemistry. 265:13290-13296 (1990).
Gilboa, E., et al., BioTechniques. 4:504-512 (1986).
Markowitz, D., et al., J. Virology 62:1120-1124 (1988).
Markowitz, D., et al., J. Virology 167:400-406 (1988).

Affiliated with

Also associated with

Rating

Antitumor pharmaceutical composition comprising IL-6 transfected does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antitumor pharmaceutical composition comprising IL-6 transfected, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumor pharmaceutical composition comprising IL-6 transfected will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-244411